Cindy R. Tahl

2021

In 2021, Cindy R. Tahl earned a total compensation of $6.5M as General Counsel and Corporate Secretary at Fate Therapeutics, a 163% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$172,000
Option Awards$500,000
Salary$430,000
Stock Awards$5,375,416
Total$6,477,416

Tahl received $5.4M in stock awards, accounting for 83% of the total pay in 2021.

Tahl also received $172K in non-equity incentive plan, $500K in option awards and $430K in salary.

Rankings

In 2021, Cindy R. Tahl's compensation ranked 1,946th out of 12,415 executives tracked by ExecPay. In other words, Tahl earned more than 84.3% of executives.

ClassificationRankingPercentile
All
1,946
out of 12,415
84th
Division
Manufacturing
736
out of 5,505
87th
Major group
Chemicals And Allied Products
281
out of 2,375
88th
Industry group
Drugs
240
out of 2,096
89th
Industry
Biological Products, Except Diagnostic Substances
72
out of 449
84th
Source: SEC filing on April 25, 2022.

Tahl's colleagues

We found five more compensation records of executives who worked with Cindy R. Tahl at Fate Therapeutics in 2021.

2021

J Wolchko

Fate Therapeutics

Chief Executive Officer

2021

Mark Plavsic

Fate Therapeutics

Chief Technology Officer

2021

Bahram Valamehr

Fate Therapeutics

Chief Research and Development Officer

2021

Yu-Waye Chu

Fate Therapeutics

Chief Medical Officer

2021

Edward Dulac

Fate Therapeutics

Chief Financial Officer

News

You may also like